Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02825966 · ClinicalTrials.gov registry record · NA
Heart Sounds Measurement Using the Wearable Cardioverter Defibrillator (HS-WCD) Study
A NA study of Heart Failure, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT02825966 is a NA study of Heart Failure that has completed, run by Zoll Medical Corporation. The registered enrollment target is 35 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02825966, a NA study of Heart Failure, has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective, validation study to evaluate the data accuracy of heart sounds recorded by the LifeVest® Wearable Cardioverter Defibrillator (WCD). These data will be compared with the heart sounds data recorded by an FDA-cleared device AUDICOR AM device.
Conditions Studied
Interventions
- DEVICE AUDICOR then LifeVest then AUDICOR
Study Locations (1)
Ohio
- MedPace Phase 1 Clinic - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02825966
The ClinicalTrials.gov registry entry for NCT02825966 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which AUDICOR then LifeVest then AUDICOR is the first listed.
NCT02825966 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02825966 about?
NCT02825966 is a clinical study titled "Heart Sounds Measurement Using the Wearable Cardioverter Defibrillator (HS-WCD) Study". A prospective, validation study to evaluate the data accuracy of heart sounds recorded by the LifeVest® Wearable Cardioverter Defibrillator (WCD). These data will be compared with the heart sounds data recorded by an FDA-cleared device AUDICOR AM device.
What is the current status of trial NCT02825966?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-02. Estimated completion is 2016-03.
What conditions does trial NCT02825966 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT02825966?
The interventions under investigation include: AUDICOR then LifeVest then AUDICOR (DEVICE).
Who is sponsoring clinical trial NCT02825966?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02825966 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.